Butler Hospital
Providence, Rhode Island, 02906, United States
NCT Number: NCT03077932
The investigators propose to develop a smartphone app (called BetterOFF) that will help patients manage opioid withdrawal during opioid medication taper and detoxification. The BetterOFF smartphone intervention will be a resource patients can access anytime and anywhere. If the BetterOFF intervention were to be effective in helping patients discontinue opioid medication, it could be integrated into the standard of care of office-based clinical practices, as well as substance use programs, thereby having a substantial public health impact.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Providence, Rhode Island, 02906, United States
Many of the growing number of patients prescribed long-term opioid medication (for a variety of reasons including a history of illicit opioid use or management of chronic pain) will express an interest in discontinuing medication. However, many patients, physically dependent on opioids, fear the withdrawal symptoms that inevitably occur with opioid medication discontinuation and will experience a decrease in their self-efficacy for abstinence at the end of a taper. As a result, tapering is often slow and done hesitantly, and relapse rates after an opioid taper are high and associated with broad consequences, including significant negative physical, mental, and social problems. Even with optimal tapering protocols, patients need novel approaches to manage the discontinuation of opiate agonist treatment. Given this important gap in opioid treatment delivery, we propose to develop a theoretically-driven, smartphone-delivered intervention (Better Off app) to help patients effectively manage the experience of opioid medication discontinuation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Phase 1 (app development) will consist of: 1) development of the BetterOFF prototype; and 2) series of usability studies with patients interested in discontinuing opioid medication.
Phase 2 (open pilot) will involve conducting a 12-week open pilot trial (n=20) to test the feasibility and acceptability of the BetterOFF app with patients tapering from opiate medication.
Time frame: 1 month post-taper
Days of opiate use at follow-up
Time frame: 1 month post-taper
Fear of withdrawal symptoms
Time frame: Baseline to 1 month post-taper
opiate withdrawal symptoms
Butler Hospital
Other
A Smartphone App to Facilitate Buprenorphine Discontinuation
Acronym: BetterOFF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04112186
Opiate Use Disorder
New York, United States
View Trial DetailsNCT04680741
Opiate Use Disorder
Warrensville Heights, Ohio, United States
View Trial DetailsNCT06848504
Chemically-Induced Disorders, Mental Disorders
Rockford, Illinois, United States
View Trial DetailsNCT05029401
Chemically-Induced Disorders, Mental Disorders
Manchester, Greater Mancherster, United Kingdom
View Trial Details